ATLANTA—Trella Health, a provider of market intelligence and integrated customer relationship management (CRM) solutions to the post-acute care industry, announced an investment in expanding its dataset—the foundation of all its products and services. The enhanced data will provide medical equipment and infusion customers with even deeper visibility into their markets through advanced metrics and analytics.
"We're acting on what our customers have been telling us," said Pierre Menard, chief technology officer at Trella Health. "While Trella provides a unique and valuable view into HME (home medical equipment) and Infusion referral patterns, we needed more data for customers to make our insights more actionable for them. I'm happy to say Trella has just made a large investment in acquiring access to one of the largest medical and RX claims data sets available anywhere, and we are incorporating that into our database and product.
"Our investment in new data will also help our post-acute provider customers," he continued. "With our new data investment, we now have access to one of the largest Medicare Advantage and Medicaid data sets available, and we'll be enhancing our post-acute provider market intelligence as well."
To continue to serve the HME and Infusion markets better, Trella has invested in the expansion of its dataset. This investment increases the number of patient lives covered to 255 million-plus annually, increases claims volume by 2x, and ultimately creates a more complete patient journey map to provide a more comprehensive view of the market.
New enhancements will include:
- 255M+ total patient lives with 125M+ payer complete lives
- 2x increase in total medical claims volume
- Adding payer-sourced claims from 150+ payers with an additional 350 payers represented in clearinghouse-sourced claims
- RX claims sourced from PBMs (available as an upgrade in 2024)
- And more
This data is sourced through clearinghouses, payers and directly from the Centers for Medicare and Medicaid Services through the Virtual Research Data Center Program. According to Trella, it is one of only a few companies deemed both a Qualified Entity by CMS and an Innovator under its VRDC program.
"A powerful data set fuels our product portfolio, allowing our customers unmatched market visibility and the insights they need to achieve their business goals," said Scott Tapp, chief executive officer at Trella Health. "We maintain an ongoing commitment to investing in our database, consistently seeking opportunities for improvement to benefit our customers. We are excited to incorporate this enhanced data into our systems for HME and Infusion customers by the end of 2023, with future plans to leverage these valuable data enhancements across our PAC provider platforms."
With a focus on supporting customer growth in an ever-changing payment landscape, Trella continuously evaluates the most impactful expansions to its data offerings.
